glp-1 obesity drug news october 21 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 Use of diabetes and anti-obesity

Vitamin D and atopic dermatitis: a systematic review and meta-analysis

Although the GPX1 Pro198Leu polymorphism, in general, did not significantly correlate with panic disorder risk, the study found a plausible association of the C allele of the GPX1 Pro198Leu polymorphism, found to be more frequent in the female cohort, with PD development

YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation

Furthermore, mitochondrial dysfunction plays a pivotal role in the progression of insulin resistance

It helps give the brain an intense and immediate hit of energy, which it needs to help the cells start to heal

5) Phase 3 CagriSema awaits FDA approval 20262027 as first dual-agonist amylin+GLP-1 medication